27.86
price down icon6.45%   -1.92
pre-market  시장 영업 전:  27.51   -0.35   -1.26%
loading

Mineralys Therapeutics Inc 주식(MLYS)의 최신 뉴스

pulisher
Feb 12, 2026

Mineralys Therapeutics launches $175M public offering - MSN

Feb 12, 2026
pulisher
Feb 11, 2026

Mineralys Therapeutics (NASDAQ:MLYS) Insider David Malcom Rodman Sells 2,171 Shares - MarketBeat

Feb 11, 2026
pulisher
Feb 11, 2026

Biotech Mineralys offers 4-year stock awards to new hires - Stock Titan

Feb 11, 2026
pulisher
Feb 11, 2026

Mineralys Therapeutics Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire

Feb 11, 2026
pulisher
Feb 10, 2026

Mineralys Therapeutics, Inc. $MLYS Shares Sold by Candriam S.C.A. - MarketBeat

Feb 10, 2026
pulisher
Feb 10, 2026

Mineralys Therapeutics, Inc. (MLYS) Stock Analysis: Exploring a 60% Potential Upside in Biotech Innovation - DirectorsTalk Interviews

Feb 10, 2026
pulisher
Feb 06, 2026

Mineralys Therapeutics Sees Unusually Large Options Volume (NASDAQ:MLYS) - MarketBeat

Feb 06, 2026
pulisher
Feb 05, 2026

Panic Selling: How sensitive is Mineralys Therapeutics Inc to inflationJuly 2025 Update & Free Low Drawdown Momentum Trade Ideas - baoquankhu1.vn

Feb 05, 2026
pulisher
Feb 04, 2026

Mineralys Therapeutics (MLYS) to Release Earnings on Wednesday - MarketBeat

Feb 04, 2026
pulisher
Feb 01, 2026

Profit Review: How sensitive is Mineralys Therapeutics Inc to inflation2025 Momentum Check & Safe Entry Trade Reports - baoquankhu1.vn

Feb 01, 2026
pulisher
Jan 30, 2026

Mineralys Therapeutics Reports Positive Phase 2 Trial Results for Lorundrostat in Hypertension and CKD - MSN

Jan 30, 2026
pulisher
Jan 30, 2026

Mineralys Therapeutics (MLYS) Files Lorundrostat NDA Following Positive Clinical Milestones - Finviz

Jan 30, 2026
pulisher
Jan 28, 2026

11 Best High Short Interest Stocks With Biggest Upside Potential - Insider Monkey

Jan 28, 2026
pulisher
Jan 28, 2026

Mineralys Awards New Hire Stock Option as Hypertension Pipeline Advances - MSN

Jan 28, 2026
pulisher
Jan 27, 2026

Mineralys Therapeutics, Inc. (MLYS) Stock Analysis: Uncovering a 53.98% Potential Upside in Biotech - DirectorsTalk Interviews

Jan 27, 2026
pulisher
Jan 27, 2026

What is HC Wainwright's Forecast for MLYS FY2030 Earnings? - MarketBeat

Jan 27, 2026
pulisher
Jan 26, 2026

Insider Trends: How sensitive is Mineralys Therapeutics Inc to inflationWeekly Trade Report & Daily Risk Controlled Trade Plans - baoquankhu1.vn

Jan 26, 2026
pulisher
Jan 26, 2026

Mineralys Therapeutics to Announce Q2 Financial Results on August 12 - MSN

Jan 26, 2026
pulisher
Jan 26, 2026

Aug EndMonth: Will CMPS benefit from rate cutsJuly 2025 Pullbacks & AI Powered Market Entry Ideas - baoquankhu1.vn

Jan 26, 2026
pulisher
Jan 25, 2026

Mineralys Therapeutics, Inc. (NASDAQ:MLYS) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat

Jan 25, 2026
pulisher
Jan 23, 2026

Avoiding Lag: Real-Time Signals in (MLYS) Movement - Stock Traders Daily

Jan 23, 2026
pulisher
Jan 23, 2026

Mineralys Therapeutics Inc call volume above normal and directionally bullish - TipRanks

Jan 23, 2026
pulisher
Jan 23, 2026

Mineralys Therapeutics’ Earnings Call Highlights Positive Outlook - MSN

Jan 23, 2026
pulisher
Jan 21, 2026

Relative Strength Alert For Mineralys Therapeutics - Nasdaq

Jan 21, 2026
pulisher
Jan 20, 2026

Rodman sells Mineralys (MLYS) shares for $13,353 - Investing.com

Jan 20, 2026
pulisher
Jan 20, 2026

Rodman sells Mineralys (MLYS) shares for $13,353 By Investing.com - Investing.com Nigeria

Jan 20, 2026
pulisher
Jan 20, 2026

David Malcom Rodman Sells 416 Shares of Mineralys Therapeutics (NASDAQ:MLYS) Stock - MarketBeat

Jan 20, 2026
pulisher
Jan 18, 2026

Fed Watch: What is Mineralys Therapeutics Incs revenue forecast2025 Market Overview & Smart Swing Trading Alerts - baoquankhu1.vn

Jan 18, 2026
pulisher
Jan 17, 2026

Activity Recap: Is EKSO a potential multi baggerAnalyst Upgrade & Fast Moving Stock Watchlists - baoquankhu1.vn

Jan 17, 2026
pulisher
Jan 16, 2026

Are Mineralys Therapeutics’ (MLYS) Executive Stock Plans Aligned With Lorundrostat’s Emerging Investment Story? - Sahm

Jan 16, 2026
pulisher
Jan 15, 2026

Insider Selling: Mineralys Therapeutics (NASDAQ:MLYS) Insider Sells 7,709 Shares of Stock - MarketBeat

Jan 15, 2026
pulisher
Jan 15, 2026

David Malcom Rodman Sells 11,367 Shares of Mineralys Therapeutics (NASDAQ:MLYS) Stock - MarketBeat

Jan 15, 2026
pulisher
Jan 14, 2026

Sell Signal: Is Mineralys Therapeutics Inc. part of any major index2025 Earnings Impact & Free High Return Stock Watch Alerts - baoquankhu1.vn

Jan 14, 2026
pulisher
Jan 14, 2026

Mineralys Therapeutics CEO Congleton sells $529k in MLYS stock By Investing.com - Investing.com Nigeria

Jan 14, 2026
pulisher
Jan 13, 2026

Mineralys Therapeutics (NASDAQ:MLYS) CEO Sells $529,618.32 in Stock - MarketBeat

Jan 13, 2026
pulisher
Jan 13, 2026

Levy, Mineralys Therapeutics CFO, sells $345k in MLYS stock By Investing.com - Investing.com Canada

Jan 13, 2026
pulisher
Jan 13, 2026

Mineralys Therapeutics MLYS officer sells $277k in stock By Investing.com - Investing.com South Africa

Jan 13, 2026
pulisher
Jan 13, 2026

Mineralys Therapeutics (NASDAQ:MLYS) Insider Sells $72,195.90 in Stock - MarketBeat

Jan 13, 2026
pulisher
Jan 13, 2026

Mineralys Therapeutics (NASDAQ:MLYS) Insider Sells $205,167.36 in Stock - MarketBeat

Jan 13, 2026
pulisher
Jan 13, 2026

Mineralys Therapeutics (NASDAQ:MLYS) CFO Sells $345,762.12 in Stock - MarketBeat

Jan 13, 2026
pulisher
Jan 13, 2026

Levy, Mineralys Therapeutics CFO, sells $345k in MLYS stock - Investing.com

Jan 13, 2026
pulisher
Jan 13, 2026

Mineralys Therapeutics MLYS officer sells $277k in stock - Investing.com

Jan 13, 2026
pulisher
Jan 13, 2026

Buybacks Report: Will Mineralys Therapeutics Inc outperform tech stocksQuarterly Risk Review & Advanced Swing Trade Entry Alerts - baoquankhu1.vn

Jan 13, 2026
pulisher
Jan 13, 2026

Patterns Watch: Whats Mineralys Therapeutics Incs historical returnJuly 2025 Rallies & Safe Capital Investment Plans - baoquankhu1.vn

Jan 13, 2026
pulisher
Jan 13, 2026

Mineralys Targets Sleep Apnea and Hypertension With Lorundrostat: What Investors Should Watch - TipRanks

Jan 13, 2026
pulisher
Jan 13, 2026

Mineralys Therapeutics, Inc. (MLYS) Stock Analysis: Unveiling a 54% Upside Potential in the Biotech Arena - DirectorsTalk Interviews

Jan 13, 2026
pulisher
Jan 12, 2026

Discipline and Rules-Based Execution in MLYS Response - Stock Traders Daily

Jan 12, 2026
pulisher
Jan 12, 2026

Trend Recap: Whats the RSI of Mineralys Therapeutics Inc stockJuly 2025 PostEarnings & Reliable Breakout Forecasts - baoquankhu1.vn

Jan 12, 2026
pulisher
Jan 11, 2026

Mineralys Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update - ADVFN

Jan 11, 2026
pulisher
Jan 09, 2026

Will Mineralys Therapeutics Inc. stock benefit from AI adoptionJuly 2025 Outlook & Risk Adjusted Buy/Sell Alerts - Улправда

Jan 09, 2026
pulisher
Jan 08, 2026

Mineralys Therapeutics (MLYS) Stock Analysis Report | Financials & Insights - Benzinga España

Jan 08, 2026
$44.80
price up icon 1.24%
$26.75
price down icon 0.19%
$100.75
price up icon 1.93%
$105.76
price down icon 3.31%
$146.17
price down icon 1.52%
biotechnology ONC
$346.42
price down icon 1.38%
자본화:     |  볼륨(24시간):